Rationale: Telethonin (also known as titin-cap or t-cap) is a 19-kDa Z-disk protein with a unique ␤-sheet structure, hypothesized to assemble in a palindromic way with the N-terminal portion of titin and to constitute a signalosome participating in the process of cardiomechanosensing. In addition, a variety of telethonin mutations are associated with the development of several different diseases; however, little is known about the underlying molecular mechanisms and telethonin's in vivo function.
T he heart is a dynamic organ capable of self-adaptation to mechanical demands, but the underlying molecular mechanisms remain poorly understood. We have previously shown that the sarcomeric Z-disk, which serves as an important anchorage site for titin and actin molecules, not only is important for mechanical force transduction but also harbors a pivotal mechanosensitive signalosome in which muscle LIM protein (MLP) and telethonin play major roles in the perception of mechanical stimuli. [1] [2] [3] Here we focus on telethonin, a striated-muscle-specific protein with a unique ␤-sheet structure (and no direct homologue genes), enabling it to bind in an antiparallel (2:1) sandwich complex to the titin Z1-Z2 domains, essentially "gluing" together the N-termini of 2 adjacent titin molecules. 4 Interestingly, the telethonintitin interaction represents the strongest protein-protein interaction observed to date. 5 Besides being phosphorylated by protein kinase D, 6 telethonin is also an in vitro substrate of the titin kinase, an interaction thought to be critical during myofibril growth. 7 The giant elastic protein titin extends across half the length of a sarcomere and is thought to stabilize sarcomere assembly by serving as a scaffold to which other contractile, regulatory, and structural proteins attach. 8 Telethonin was shown to interact with MLP, hypothesized to be part of a macromolecular mechanosensor complex and to play a role in a subset of human cardiomyopathies. 2 In this context, telethonin interacts with calsarcin-1 (also known as FATZ-2 or myozenin-2, a gene recently shown to cause cardiomyopathy 9 ), ankyrin repeat protein 2, small ankyrin-1 (a transmembrane protein of the sarcoplasmic reticulum), 10 and minK (a potassium channel ␤ subunit). [11] [12] [13] [14] In addition, telethonin was shown to interact with MDM2 15 and MuRF1, 16 E3 ubiquitin ligases with strong impact on cardiac protein turnover as well as with the proapoptotic protein Siva. 17 Recessive nonsense mutations in the telethonin gene are associated with limb-girdle muscular dystrophy type 2 G 18 -20 and heterozygous missense mutations with dilated and hypertrophic forms of cardiomyopathy 1, 21, 22 as well as with intestinal pseudo-obstruction. 23 Interestingly, a naturally occurring telethonin variant that has a Glu13 deletion (E13del telethonin) was initially found in patients affected by hypertrophic cardiomyopathy 21 and then later in healthy, unaffected individuals. 24, 25 However, the molecular consequences of the E13del variant, especially on the telethonin-titin interaction, as well as telethonin mediated pathways in general remain unclear.
Methods
Please see also the detailed methods description in the Online Supplemental material, available at http://circres.ahajournals.org.
Sarcomere Stretch and Titin Localization
Myofibrils were prepared from telethonin-deficient or wildtype tissue as described previously. 26 In Vitro Protein Interaction Assay Z1Z2 titin, MLP, telethonin, and its mutants were expressed and purified as previously described. 27 Z1Z2-telethonin complexes were formed and analyzed on native gels and gel filtration columns as previously described. 4 
Antibodies
In the current project we used 2 different antitelethonin antibodies: a mouse antitelethonin polyclonal antibody raised against a recombinant His-tagged human full-length telethonin (Western blots, immune precipitations, mouse heart, and human heart sections) and a rat polyclonal antitelethonin antibody (immunofluorescence in neonatal rat cardiac myocytes). Both the mouse and rat antibodies to human telethonin were produced by immunizing, respectively, Balb/C mice or LOU/Nmir rats with purified recombinant full-length telethonin protein (1 to 167 aa), and their specificity was checked by their ability to detect telethonin on Western blots of human heart and skeletal muscle protein. Anti-Z1Z2 titin antibody was a kind gift of Prof. S. Labeit. We used as well p21WAF1 EA10 (Calbiochem), Mdm2 2A9 and 2A10, myc 4A6 (Upstate) and actin AC15 (Abcam), antip53 (DO-1, FL 393, Santa Cruz), and mouse monoclonal p53 (1C12, Cell signaling), mouse monoclonal anti ␣-actinin (Sigma), and phalloidin conjugated Alexa 350 antibody. The secondary antibodies used were Alexa-abeled 633 antirat, Alexa-labeled 488 antirabbit, and Alexa-labeled 488 antimouse (Invitrogen) antibody (please see also the Online Supplemental Material for additional information).
Statistics
All animals used in the experiments were matched on age and sex. All assays were analyzed in "double-blind" fashion. T tests were used to analyze differences in echocardiography (nϭ8 to 9 animals per group) and for the analysis of Z-disks following sarcomere stretch. Whenever more than 2 groups were compared, analysis of variance (ANOVA) tests followed by Bonferroni's Multiple Comparison test were applied. Statistical significance was reached at PϽ0.05.
Results
To be able to perform a detailed functional analysis of cardiac performance, we generated telethonin-deficient mice by homologous recombination, replacing exons 1 and 2 with a Lac Z-neomycin cassette (Figure 1 ). Using this approach, telethonin was found to be transcribed as early as embryonic day 10.5 (not shown). Telethonin is a late-in protein; as such, it is not a surprise that telethonin-deficient mice are born in the expected Mendelian ratios and that this protein is apparently not required during heart development. 28, 29 In contrast to recently published zebrafish and xenopus knock-down models 30 Table I ) as well as by in vivo heart catheterization using 3-to 4-month-old telethonin Ϫ/Ϫ mice under basic conditions did not reveal any abnormal parameters. Histological analysis of the spontaneous cardiac phenotype of telethonin Ϫ/Ϫ mice revealed no alterations, including the amount of extracellular matrix deposition, (see next paragraph), and changes in titin-isoform composition that could be excluded on the basis of gel electrophoresis (Online Figure I) . Epifluorescence experiments showed unaltered global intracellular Ca 2ϩ handling (Online Figure II) and immunohistochemistry as well as immunogold electron microscopy did not reveal any defects in telethonin-deficient Z-disks (Online Figure III) .
Telethonin was shown to interact directly with the potassium channel subunit minK, 13 as well as with different sodium channels such as SCN5A 23 ; as a consequence, we performed extensive analyses of electrocardiograms (ECG) in vivo as well as patch-clamp experiments in vitro, but did not find any significant differences in ECG parameters such as PQ interval, QRS width, QT interval, or action-potential repolarization between control littermates and telethonindeficient animals, without any occurrence of early or delayed after depolarizations in either group. The telethonin-minK or telethonin-SCN5A interaction may thus have little physiological relevance in the heart, at least in the mouse model (Online Figure IV) . This remarkable mild cardiac phenotype despite loss of telethonin is supported by another recently published study of telethonin knock-out mouse, in which the same approach has been used to inactivate telethonin (ie, exons 1 and 2 have been replaced by a Lac Z neomycin cassette) and in which the skeletal muscle phenotype has been analyzed but almost no pathology has been detected under spontaneous conditions. 32 Telethonin was shown to interact with the N-terminal Z1Z2 titin and, as such, might have an important function in mechanically linking 2 titin molecules together. 4 Again, surprisingly from what we expected, a stretch of single isolated myofibrils obtained from telethonin Ϫ/Ϫ heart or skeletal muscle did not cause any changes in Z-disk architecture or displacement of the titin N-terminus from the Z-disk, even when the sarcomeres were extended stepwise to (unphysiological) lengths of Ͼ3.2 m to reach very high passive forces of tens of mN/mm 2 ( Figure 2A and 2B). In contrast, compromised anchorage of the titin N-terminus was observed after removal of actin from cardiac sarcomeres (using a Ca 2ϩ -independent gelsolin fragment 26 ), suggesting that telethonin is mechanically relevant only when there is additional disturbance of the Z-disk (Figure 2A and 2B), such as impairment of the ␣-actinin-mediated titin-actin cross-links.
Moreover, we reconstituted in vitro a complex consisting of telethonin and the N-terminal (Z1-Z2) titin domains and analyzed the effects of different human telethonin mutations on this complex formation. In contrast to several point mutations tested previously, 4 the E13del variant, which because of its presence in healthy unaffected individuals has been regarded as a polymorphism 24, 25 rather than a disease- Probing functional consequences of telethonin deficiency at the subcellular and organismic levels. A and B, Myofibrils were isolated from either wildtype (WT) or homozygous telethonin-deficient (KO) mouse hearts and stretched to a desired sarcomere length (SL) under nonactivating conditions. Then, myofibrils were stained with an antibody to the telethonin-binding titin domains, Z1-Z2, and the secondary ones labeled using FITC-conjugated IgG. A, Phase-contrast (pc) and immunofluorescence (Z1Z2) images of stretched myofibrils from cardiac muscle before actin extraction; telethonin-deficient skeletal muscle; and cardiac muscle after actin extraction using a Ca 2ϩ -independent gelsolin fragment (shown are myofibrils at 2 different stretch states). Scale bar, 2 m. B, (top) Quantitation of the broadness of the titin label in the Z-disk by determining the full width at half-maximum (FWHM) peak height on intensity profiles along the myofibril axis. (bottom) Average widths of Z1Z2-titin label in WT and KO cardiac myofibrils at different SLs, before and after actin extraction. Data are means Ϯ SD (nϭ3 to 6). *PϽ0.05 in Student t test. C, Pull-down with MLP. N-terminus of titin (Z1Z2, used as a control), Tel (1 to 90), Tel (1 to 90, dE13), Tel (1 to 90, E13A), Tel (1 to 90, E13R), and Tel (1 to 90, E13W) were incubated with a recombinant GST-MLP fusion protein and pulled down with glutathione-sepharose 4B beads (anti-GST antibody antirabbit, Pharmacia Biotech, Sweden). D, Pull-down with Z1Z2. Same experiment as in C, except that instead of MLP an H-tagged N-terminus of titin Z1Z2 was used (pull down with Ni 2ϩ -NTA beads (QIAGEN, Germany), blot with antibody against telethonin). E, Native PAGE analysis of titin/telethonin complexes formed from telethonin and its mutants with Z1Z2. On the native gel, only the Z1Z2-telethonin complex and Z1Z2 were visible. F, Analysis of the Z1Z2-telethonin complex formation by size exclusion chromatography in combination with static light scattering. The complexes were loaded onto a sephadex column, molecular masses were calculated to be 23.0 (Z1Z2) and 55.4 (Z1Z2-telethonin complex) kDa. G, Structure of the telethonin-titin Z1-Z2 complex, the arrow indicates glutamate 13 (E13), important for stabilizing the ␤-hairpin structure. H, Functional analysis of telethonin deficiency in vivo: 2 to 3 weeks after transverse aortic constriction (TAC), telethonin causing mutation, 21 lost the ability to bind the titin N-terminus ( Figure 3E through 3H) . Consistent with previous data, 4 the deletion of this residue in telethonin leads to a loss of proper formation of the telethonin ␤-hairpin structure, which forms the basis for the titin binding. Given the available information on heterozygous and homozygous telethonin deficiency reported here and the fact that heterozygous loss of telethonin is not associated with any phenotype (Figure 3H ), one possible conclusion is that E13del telethonin is probably a harmless, naturally occurring variant unable to bind titin, hence supporting our view that telethonin, at least in mammals, performs no important structural functions. However, additional effects of the E13del telethonin variant cannot be excluded, and homozygous patients have not been reported.
The fulminant defects observed after actin removal in the myofibril stretch experiments led us to increase the biomechanical load under in vivo conditions by transverse aortic constriction (TAC). Two to 3 weeks after this intervention, telethonin Ϫ/Ϫ animals developed maladaptive cardiac hyper- trophy and severe heart failure as judged by clinical signs and echocardiography ( Figure 3H ).
Moreover, we found an increase in focal fibrosis as well as a significant increase in TUNEL positive cells in the telethonin Ϫ/Ϫ animals following the TAC intervention pointing to apoptosis as a possible cause of cell death (Figure 2A through 2D) . A detailed analysis revealed that primarily cardiac myocytes were TUNEL positive, and gene expression analysis revealed differential expression of several genes involved in the apoptotic pathway (Online Figures V and VI) .
Cardiac apoptosis can be efficiently induced by the tumor suppressor gene product p53, 33 a protein known to be polyubiquitinylated and marked for degradation by the E3 ubiquitin ligase MDM2. 34 Western blot analysis revealed increased p53 levels in the telethonin Ϫ/Ϫ animals following TAC ( Figure 2E and 2F) , whereas the apoptosis repressor with caspase recruitment domain (ARC)-another important heart specific survival factor-remained unchanged (not shown). We also found significant increases in p21 and Caspase 8 mRNA expression, both of which are p53 target genes ( Figure 2G, Online Figure VI) , and a significant Note that telethonin is not detectable in telethonindeficient hearts, and in telethonin-deficient animals, just a very few nuclei having an apparent tendency to be positive for p53 were observed (boxed regions). However, this phenomenon was so rare that it does not differ substantially from WT sham-operated mice. Note as well that in wildtype mice, telethonin is present in the nuclei after TAC, where it colocalizes with p53. Inserts are higher magnifications of the boxed regions (p53 in red, DAPI [nuclear staining] in blue, telethonin or ␣-actinin in green mark cardiomyocytes). E, It is also evident that p53 nuclear expression levels are much higher in telethonin knockout mice than in wildtype mice after TAC (graph; ***PϽ0.005; error bars indicate standard deviation [SD]). Figure 5 . Telethonin/p53 interaction. A, After 48 hours of silencing with siRNA telethonin, neonatal rat cardiomyocytes were incubated with doxorubicin (1 mol/L) for the next 18 hours. The cells were harvested and whole-cell extracts were used for Western blot analysis. Membranes were probed with mouse polyclonal telethonin as well as with rabbit polyclonal p53 antibodies (Santa Cruz). GAPDH was used as a loading control. Please note the strong induction of p53 when telethonin is knocked down. B, U2OS cells were transfected with myc-telethonin and treated with nutlin-3. Cells were harvested 36 hours posttransfection in RIPA buffer. Cell lysates were used for Western blot analysis. *Unspecific signal. C, Interaction between telethonin and p53. This interaction was detected in U2OS cells between endogenous p53 and transfected HA-tagged telethonin in the presence of Nutlin (8 mol/L). The IP samples were subjected to SDS-PAGE and blotted and the blot probed with antip53 monoclonal antibody (DO-1, Santa Cruz). Lane 1: U2OS cells transfected with empty plasmid; IP was performed with anti-HA antibody. Lane 2: telethonin transfected U2OS cells; IP was performed with anti-HA antibody. D, Pulldown and complex purification of full-length p53-telethonin complexes. Left: Pull-down experiment using His6-Z-tagged wild type and E13del mutant telethonin and empty His6-Z-tagged vector as a control. Protein complexes were eluted from a Ni-NTA column and analyzed by SDS-PAGE electrophoresis followed by transfer to nitrocellulose membrane. The presence of p53 protein was detected by anti-p53 antibody staining. Right: The elution peaks of complexes formed with wild type or E13del telethonin were analyzed on native PAGE (upper panel) and SDS-PAGE (lower panel). E, Telethonin wildtype or E13del mutant form a complex with the DNA-binding domain of p53 (p53DBD). The complex was separated using size-exclusion chromatography (Superdex 200), and the molecular weight was measured by static light scattering. increase in nuclear p53 (Figure 4) , supporting the finding of enhanced p53 protein levels.
Interestingly, myostatin has been implicated in the regulation of p53 and p21 expression; it is a negative regulator of cardiac growth [35] [36] [37] [38] and is upregulated under stress. 39 -41 Moreover, myostatin has also been associated with fibrosis. 42 Most important, telethonin has been shown previously to interact with myostatin and to inhibit its expression. 43 Thus myostatin might be able to cause the observed effects, but we did not detect any significant changes in myostatin mRNA or protein expression (Online Figures VII and VIII) .
We also performed in vitro experiments in neonatal rat cardiomyocytes, in which we knocked down telethonin and found a strong induction of p53 after additional doxorubicin treatment (a drug known to cause oxidative cellular stress and to induce stress-responsive genes 44 ; Figure 5A ). In addition, we found evidence of telethonin being present in the nuclei of neonatal rat cardiomyocytes at early stages of culture (up to 2 days after plating; not shown).
Transient overexpression of telethonin in U2OS cells led to a strong downregulation of endogenous p53 ( Figure 5B , lane 2 versus lane 4). These effects were not observed in the presence of nutlin-3, a compound preventing the interaction between p53 and MDM2, suggesting that MDM2 is required for the effects of telethonin on p53 degradation. Accordingly, expression of classical p53-responsive genes, p21 and MDM2, were suppressed owing to the diminished p53 levels. This prompted us to investigate the underlying molecular mechanism in more detail, and we found direct interaction of telethonin and MDM2 by coimmunoprecipitation assays (Online Figure IX) , supporting earlier observations by Tian and coworkers. 15 In addition, a direct interaction of p53 and telethonin was detectable by coimmunoprecipitation experiments ( Figure 5C ) as well as pull-down assays ( Figure 5D ). Native and SDS-PAGE gel electrophoresis indicated the formation of a high-molecular weight complex (Ϸ150 kDa) between full-length telethonin (wildtype and E13del) and full-length p53 in vitro ( Figure 5D , right panels).
Static light scattering and NMR analysis additionally showed that the interaction involves the p53 DNA-binding domain (p53DBD). Static light scattering indicated a molecular weight of 163 kDa for this complex, suggesting that it might consist of multiple telethonin and p53DBD molecules ( Figure 5E ). NMR spectroscopy further confirms that the telethonin interaction involves the p53DBD ( Figure 5F ). NMR chemical shift differences between the free and telethonin-bound p53DBD reveal that telethonin contacts the ␤-sheet of p53DBD, at a site that is remote from the DNA-binding interface ( Figure 5F , Online Figure X) . Fluorescence polarization (FP) experiments ( Figure 5G ) and surface plasmon resonance (SPR, Biacore) experiments (Online Figure X) show that the interaction between telethonin and p53DBD has a low micromolar dissociation constant (K D ϭ2.2Ϯ0.2 mol/L and 0.765Ϯ0.03 mol/L for FP and SPR, respectively; Online Figure X) . These values are comparable to other protein-protein interactions that have been mapped to p53DBD. [45] [46] [47] It is interesting to note that the interaction of telethonin with titin ( Figure 3G ) also preferentially involves the ␤-sheets of the titin Z1-Z2 domains forming intermolecular ␤-strand contacts. Similar interactions might contribute to the stabilization of the telethoninp53DBD complex.
We performed as well a series of F-actin, ␣-actinin, telethonin, and p53 colocalization studies and found that p53, in contrast to the Z-disk localization of telethonin, is not clearly detectable under spontaneous conditions, neither in the in vivo setting nor in isolated neonatal rat cardiomyocytes in vitro (Online Figures XI and XII) . However, after biomechanical or oxidative stress in vivo, such as TAC (Figure 5 ), or doxorubicin treatment in vitro and in vivo (Online Figures  XIII and XIV) , we observed a strong induction of p53 in cardiomyocyte nuclei, which is well in accordance with previously published data on p53. 48, 49 Moreover, under both stress conditions, telethonin colocalized with p53 in cardiomyocyte nuclei (Online Figures XIII and XIV) . However, an even stronger increase in p53 nuclear expression was observed after TAC in telethonin-deficient animals, supporting the results of our previous Western blot anal- ysis ( Figure 2 and Figure 4 ). Telethonin/p53 colocalization was also observed when we transfected neonatal rat cardiomyocytes in vitro using a GFP-telethonin construct (Online Figure XV) .
On the basis of these data, we assumed that telethonin at least supports MDM2-mediated p53 degradation. As a consequence we aimed to analyze the effects of telethonin overexpression on myocardial function under in vivo conditions and generated telethonin transgenic animals. We used the myocardium-specific alpha myosin heavy chain promoter and a FLAG-tagged mouse telethonin cDNA ( Figure 6 ). Again, to our surprise, these animals did not exhibit any spontaneous phenotype (Online Table II) . 50 Of note, they develop less apoptosis as well as less p53 expression in comparison with wildtype littermate controls after TAC ( Figure 6 ). The decrease in apoptotic (TUNEL positive) cells in telethonin transgenic animals is particularly interesting and might indicate potential protective effects of telethonin overexpression.
We then assumed that p53 determines the negative outcome in telethonin-deficient animals following biomechanical stress, and we used a transgenic line overexpressing a well-characterized dominant negative p53 mutant (ie, the Arg193Pro mutation) 51, 52 to inactivate this protein in the telethonin Ϫ/Ϫ background ( Figure 7A ). The dnp53/ telethonin Ϫ/Ϫ double transgenic animals did not develop any spontaneous phenotype, and they did not exhibit any significant change in myocardial function following TAC. However, genetic inhibition of p53 in the telethonin deficient background significantly inhibited the increase in apoptosis found after biomechanical stress in telethonin Ϫ/Ϫ animals alone ( Figure 7B ).
In order to study telethonin mRNA expression in the human heart we analyzed myocardial samples from end-stage heart failure patients and found significant downregulation in comparison with normal donor hearts ( Figure 7C ), as well as an increase in nuclear telethonin ( Figure 7D ). This may have implications for p53 expression and p53-related apoptosis, both of which have previously been shown to be elevated in these patients. We also found downregulation of telethonin in acute donor organ failure, suggesting that this effect is not restricted to the setting of chronic end-stage failure. 51 These mice have been crossed into the telethonin knockout background resulting in dn p53 / telethonin double transgenic animals. The numbers refer to p53 exons (gray boxes); 1/2 indicates that a fusion was made between exons 1 and 2. B, Quantification of apoptosis after transverse aortic constriction (TAC). Note that p53 inhibition in the telethonin knockout background prevents the increase in apoptosis. Wildtype (nϭ15), telethonin Ϫ/Ϫ (nϭ11), telethonin transgenic (nϭ4), dn p53 (nϭ13), and dn p53/telethonin double transgenic animals (nϭ7); error bars indicate standard deviation (SD). C, Quantification of telethonin mRNA by quantitative real-time PCR in ventricular myocardium from normal donor organs (nϭ8), from end-stage heart failure patients taken at the time of transplantation (heart failure nϭ7), and from failing donor organs with EF Ͻ30% (nϭ9). Data are shown as mean Ϯ standard deviation (SD). *PϽ0.05, **PϽ0.01 versus donors. D, Analysis of telethonin localization in human hearts. Note that under physiological (no disease) conditions, telethonin is present at the sarcomeric Z-disk but not in cardiac nuclei (upper panel). In heart failure, telethonin is less present at the sarcomeric Z-disk and more present in cardiac nuclei (lower panel) (DAPI [nuclear staining] in blue, telethonin in green).
Discussion
Here we demonstrate a model for which a primary defect in an integral Z-disk component is not associated with any cardiac phenotype or functional abnormality under basal conditions. 53 However, pressure overload causes a maladaptive response in homozygous telethonin Ϫ/Ϫ hearts, ultimately leading to global heart failure in vivo. Loss of the p53-ligand telethonin is associated with an increase in p53 as well as elevated apoptosis following an increase in afterload, which is the first description of a Z-disk component to do so. Moreover, by binding to p53's DNA-binding domain, telethonin is potentially able to repress the function of this important transcription factor.
Telethonin, which was shown to be phosphorylated in vitro by the titin kinase, 7 does not seem to have a function during embryonic development in vivo. A recent study 54 reported a defect in C2C12 myoblast differentiation when telethonin was downregulated by the use of siRNAs. It remains to be elucidated whether there are differences in vivo and in vitro or whether the telethonin siRNAs per se exhibit off target effects that account for the observed differences. In addition, loss of telethonin in zebrafish or xenopus is associated with a spontaneous defect 30, 31 ; as such, it will be important to elucidate in future whether telethonin in mammalian hearts acquired additional functions during evolution, whether sofar-unknown telethonin homologue genes are upregulated, or whether differences in Z-disk structure account for the observed differences. Our data are generally consistent with a recent report whereby telethonin binds in an antiparallel (2:1) sandwich complex to the titin Z1-Z2 domains. 4 However, telethonin clearly is not required to stabilize the sarcomere structure. Instead, telethonin may serve as a pivotal element in cardiac signaling by controlling apoptosis and cell death via p53. Our data are compatible with a direct molecular link between the sarcomeric Z-disk and cardiac performance, as well as gene transcription and cell survival (mechanotranscriptional coupling, or MTC), although additional data need to be provided to entirely support such a functional link. It might well be that Z-disk proteins carry at least 2 different functions: (1) a structural function that might be dismissible, particularly in "peripheral" Z-disk proteins, and (2) a regulatory function, which as in this case, might be much more important. One implication of this could be that cardiomyopathy and associated heart failure, which can be caused by mutations in Z-disk components (now regarded as a "hot spot" for these mutations 55 ), might be seen as a disease caused by "defects in cardiac regulation" or of "defects in mechanotranscriptional coupling."
In conclusion, this study might change the previous concept of Z-disk structure, which we now suggest to also be a pivotal node for apoptosis, essentially by linking telethonin to p53 (Figure 8 ). In contrast to previous views, telethonin is not an indispensable component of the cardiac titin anchoring system, and cardiac-specific telethonin overexpression is not immediately associated with Z-disk pathology and as such is compatible with life. Instead, under normal conditions, actin cross-linking may be sufficient to keep the sarcomere structure viable, despite loss of telethonin. With an increase in hemodynamic load or an increase in biomechanical or oxidative stress, however, telethonin deficiency leads directly to enhanced p53 levels and as such promotes an increase in apoptosis and cell death, thus initiating the development of heart failure, an effect that might be called mechanoptosis. On the basis of our in vitro and in vivo data, we assume that telethonin binds to p53 as well as to the E3 ubiquitin ligase MDM2, essentially supporting p53 degradation. Loss of or mutations in telethonin, together with an increase in biomechanical stress, causes maladaptation, apoptosis, and global heart failure.
